Abstract:Background: Deep-learning convolutional neural networks (CNNs) have outperformed even experienced dermatologists in dermoscopic melanoma detection under controlled conditions. It remains unexplored how real-world dermoscopic image transformations affect CNN robustness. Objectives: To investigate the consistency of melanoma risk assessment by two commercially available CNNs to help formulate recommendations for current clinical use. Methods: A comparative cohort study was conducted from January to July 2022 at the Department of Dermatology, University Hospital Basel. Five dermoscopic images of 116 different lesions on the torso of 66 patients were captured consecutively by the same operator without deliberate rotation. Classification was performed by two CNNs (CNN-1/CNN-2). Lesions were divided into four subgroups based on their initial risk scoring and clinical dignity assessment. Reliability was assessed by variation and intraclass correlation coefficients. Excisions were performed for melanoma suspicion or two consecutively elevated CNN risk scores, and benign lesions were confirmed by expert consensus (n = 3). Results: 117 repeated image series of 116 melanocytic lesions (2 melanomas, 16 dysplastic naevi, 29 naevi, 1 solar lentigo, 1 suspicious and 67 benign) were classified. CNN-1 demonstrated superior measurement repeatability for clinically benign lesions with an initial malignant risk score (mean variation coefficient (mvc): CNN-1: 49.5(±34.3)%; CNN-2: 71.4(±22.5)%; p = 0.03), while CNN-2 outperformed for clinically benign lesions with benign scoring (mvc: CNN-1: 49.7(±22.7)%; CNN-2: 23.8(±29.3)%; p = 0.002). Both systems exhibited lowest score consistency for lesions with an initial malignant risk score and benign assessment. In this context, averaging three initial risk scores achieved highest sensitivity of dignity assessment (CNN-1: 94%; CNN-2: 89%). Intraclass correlation coefficients indicated 'moderate'-to-'good' reliability for both systems (CNN-1: 0.80, 95% CI:0.71-0.87, p < 0.001; CNN-2: 0.67, 95% CI:0.55-0.77, p < 0.001). Conclusions: Potential user-induced image changes can significantly influence CNN classification. For clinical application, we recommend using the average of three initial risk scores. Furthermore, we advocate for CNN robustness optimization by cross-validation with repeated image sets. Trial registration: ClinicalTrials.gov (NCT04605822).

Comprehensive analysis of clinical images contributions for melanoma classification using convolutional neural networks

Two-Stage Deep Neural Network Via Ensemble Learning for Melanoma Classification

Melanoma Classification Using a Novel Deep Convolutional Neural Network with Dermoscopic Images

Melanoma Classification in Dermoscopy Images via Ensemble Learning on Deep Neural Network

Using Multiple Dermoscopic Photographs of One Lesion Improves Melanoma Classification via Deep Learning: A Prognostic Diagnostic Accuracy Study

Melanoma identification and classification model based on fine-tuned convolutional neural network

Unveiling the power of convolutional neural networks in melanoma diagnosis

Consistency of convolutional neural networks in dermoscopic melanoma recognition: A prospective real-world study about the pitfalls of augmented intelligence

A Comparative Analysis Towards Melanoma Classification Using Transfer Learning by Analyzing Dermoscopic Images

Computerizing the first step of the two-step algorithm in dermoscopy: A convolutional neural network for differentiating melanocytic from non-melanocytic skin lesions

DePicT Melanoma Deep-CLASS: a deep convolutional neural networks approach to classify skin lesion images

Interpretable Classification from Skin Cancer Histology Slides Using Deep Learning: A Retrospective Multicenter Study

Skin Lesion Diagnosis Using Convolutional Neural Networks

The effect of hair removal and filtering on melanoma detection: a comparative deep learning study with AlexNet CNN

Expert-Level Diagnosis of Nonpigmented Skin Cancer by Combined Convolutional Neural Networks

Deep Learning With Optical Coherence Tomography for Melanoma Identification and Risk Prediction

A novel deep learning framework for accurate melanoma diagnosis integrating imaging and genomic data for improved patient outcomes

Enhancing Melanoma Diagnosis with Advanced Deep Learning Models Focusing on Vision Transformer, Swin Transformer, and ConvNeXt

Classification of melanoma skin Cancer based on Image Data Set using different neural networks

Malignancy Prediction and Lesion Identification from Clinical Dermatological Images

Interpretable Diagnosis for Whole-Slide Melanoma Histology Images Using Convolutional Neural Network